Torthaí cuardaigh - Marice Alcantara

  • 1 - 6 toradh as 6 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

    Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 de réir Jeremy Hall, Zhuoran Zhang, S. Bhattacharya, Dongfang Wang, Marice Alcantara, Liang Yong, Piotr Swiderski, Stephen J. Forman, Larry W. Kwak, Nagarajan Vaidehi, Marcin Kortylewski

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity

    Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity de réir Dayson Moreira, Sagus Sampath, Haejung Won, Seok Voon White, Yu‐Lin Su, Marice Alcantara, Chongkai Wang, Peter P. Lee, Ellie Maghami, Erminia Massarelli, Marcin Kortylewski

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

    Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma de réir Alex Chehrazi‐Raffle, Luís Meza, Marice Alcantara, Nazlı Dizman, Paulo Gustavo Bergerot, Nicholas Salgia, Joann Hsu, Nora Ruel, Sabrina Salgia, Jasnoor Malhotra, Ewa Karczewska, Marcin Kortylewski, Sumanta K. Pal

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

    Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy de réir Marice Alcantara, Wilson S. Tang, Dongfang Wang, Damian Kaniowski, Elaine Kang, Nazlı Dizman, Alex Chehrazi‐Raffle, Luís Meza, Zeynep Büşra Zengin, Jérémy Hall, Joann Hsu, Colt A. Egelston, Dayson Moreira, Alan Horsager, Sumanta K. Pal, Marcin Kortylewski

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

    Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial de réir Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, Marice Alcantara, Tanya B. Dorff, Yung Lyou, Paul Frankel, Yujie Cui, Valerie Mira, Marian Llamas, Joann Hsu, Zeynep Büşra Zengin, Nicholas Salgia, Sabrina Salgia, Jasnoor Malhotra, Neal Shiv Chawla, Alex Chehrazi‐Raffle, Ramya Muddasani, John D. Gillece, Lauren Reining, J.M. Trent, Motomichi Takahashi, Kentaro Oka, Seiya Higashi, Marcin Kortylewski, Sarah K. Highlander, Sumanta K. Pal

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

    Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial de réir Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza, Jasnoor Malhotra, Xiaochen Li, Tanya B. Dorff, Paul Frankel, Marian Llamas-Quitiquit, Joann Hsu, Zeynep Büşra Zengin, Marice Alcantara, Daniela V. Castro, Benjamin Mercier, Neal Shiv Chawla, Alex Chehrazi‐Raffle, Regina Barragán-Carrillo, Salvador Jaime‐Casas, Ameish Govindarajan, John D. Gillece, Jeffrey M. Trent, Peter P. Lee, Thomas P. Parks, Motomichi Takahashi, Atsushi Hayashi, Marcin Kortylewski, J. Gregory Caporaso, Keehoon Lee, Abhishek Tripathi, Sumanta K. Pal

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: